Top Story
Grass-roots effort drives cloud business case
At Harvard Medical School, the IT department has become both business partner and service provider to users. The venerable institution has built a cloud computing solution based on user participation, and in so doing built its business case for the cloud. Read more
Latest News
Also Noted
> An ex-NYU professor says he was asked to "spin" data from of a vaccine trial and then fired when he reported the misconduct. Item
> Simulations Plus has launched version 7.0 of GastroPlus software for simulating drug absorption, pharmacokinetics, and pharmacodynamics. Simulations Plus release
> Symyx Notebook 6.5 from Accelrys supports chemical process development, production scale-up, and administrative compliance. Accelrys release
> Answerthink, maker of the EzLifeSciences solutions, has joined the SAP Business All-in-One fast-start program. Answerthink release
> Novella Clinical has named Jane Bentley VP for clinical operations, leading European clinical operations. Novella announcement
Read more >>Latest Comments
- I just wanted to say....Thank You Tracey for ...
- Is there some math secret here I'm not unders...
- We are feeling the pain of flawed Pharma poli...
- Say, how about a Follica update?
- "A CMS spokesman tells us this is a special c...
- You quote the CMS announcement incorrectly an...
- The Alzheimers Reading Room has clear, concis...
Top News
Risk approach comes to site monitoring
An emerging risk-based approach to site monitoring uses partial source document verification in place of traditional full source document verification (SDV) coverage. In the risk-based approach, monitoring targets the most critical review activities at sites requiring the highest level of attention. Article
UK study supports dose-response modeling
Researchers studying an overactive bladder treatment have concluded that dose-response models can be used to predict outcomes for doses not studied. Article
From The Network
Press Releases
- Novartis and collaborators discover novel antimalarial drug candidate
- Internal memo on Roche's Operational Excellence project
- Medical Affairs Report Outlines Resource Needs for Group Success
- Roche announces Operational Excellence initiative
- Concordia Pharmaceuticals, Inc. Signs First Licensing Agreement with Ono Pharmaceutical Co, Ltd. for Salirasib
- Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278
